Editas Medicine, Inc. (EDIT)
NASDAQ·Healthcare·Biotechnology
$3.07
+6.06%
Mkt Cap $282.85M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (19 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+95.8%
Consensus $6.00 vs current $3.07
NASDAQ·Healthcare·Biotechnology
$3.07
+6.06%
Mkt Cap $282.85M
Buy
2
Hold
0
Sell
0
Price Target (19 analysts)
$6.00
Range $6.00 – $6.00
+95.8%
Consensus $6.00 vs current $3.07